-
Drovix Launches In-House Multi-Asset Liquidity and Execution Stack for Sub-Millisecond Fills, Tighter Spreads
-
Australia charges man with trying to pass Ukraine military intel to Russia
-
'So bad it's good': rough animated film becomes surprise Chinese hit
-
Ex-Pakistan PM Khan taken back to jail after hospital checks: govt
-
'I'll adapt': First pregnant candidate navigates French presidential race
-
China, Indonesia hold talks on security, defence
-
Hong Kong convicts Tiananmen vigil activists of inciting subversion
-
Train to nowhere? South Korea's lonely push for peace with the North
-
The Hong Kong Tiananmen vigil activists convicted in national security trial
-
Australia's Hussey mulls role with England for Ashes series
-
Eel-powered Japan whizz-kid, 11, chases Asian Games history
-
Indian captain 'scapegoat' in Britain's Russia shadow fleet case, wife says
-
Asian markets extend rally as traders assess US Treasuries pledge
-
Rosenior seeks to match Paris FC's capital ambition as Ligue 1 returns
-
Barcelona enter new era as Flick targets La Liga hat-trick
-
Inter set for Serie A title defence as Milan get Amorim reboot
-
Pogacar favourite for Vuelta with Grand Tour treble in sight
-
'Greatest' Springboks face All Blacks in clash of juggernauts
-
Bangladesh coach Simmons wary of Australia backlash in second Test
-
William and Harry: Britain's warring royal brothers
-
Hong Kong Tiananmen activists to receive national security verdict
-
UN holds second informal poll for next leader
-
Who are the candidates vying to lead the UN?
-
In US mining hub, black lung rates soar
-
Swiatek into Cincinnati semis after Rybakina injury
-
Champions Arsenal embrace being 'hunted' as Premier League returns
-
University suspends academic behind Jason Arday plagiarism charges
-
World No.2 Rybakina retires from Cincinnati clash with Swiatek
-
Key European leaders demand Israel halt West Bank settlement project
-
'I heard you missed me': Melania Trump jokes about month out of spotlight
-
Kiwi Ears Stardust: The Art of Natural Balance
-
IRA-Eligible Gold: Rules, Approved Coins, and Best Gold Dealers (Guide Released)
-
McIlroy bounces back to share BMW Championship lead
-
Amazon Prime Video to invest $2 bn in Latin America productions
-
Cobolli fueled by candy in sweet defeat of Paul
-
Panama Canal to reduce shipping over El Nino-fueled drought
-
Jailed Pakistan ex-PM Khan moved to hospital on court order: party
-
Maradona trial on hold over possible medical evidence mix-up
-
Pogacar eyes 'missing' piece ahead of Vuelta return
-
'Green dilemma': China's solar boom hurt birds, says study
-
US, Canada 'very close' to trade deal, Ottawa says, as details emerge
-
Pegula hangs on to dispatch Anisimova, reach Cincinnati semi-finals
-
Ronaldinho returns in search of 'beautiful' 300th goal
-
US charges woman with IS-inspired plot to blow up New York State Capitol
-
US pushes allies, China to back Trump's economic war on Iran
-
What a record-breaking El Nino could mean for the world
-
Former NBA MVP Harden reportedly set to return to Cavaliers
-
Duplantis edges Karalis to win Lausanne Diamond League pole vault
-
Brook makes Pakistan pay for drop as England dominate first Test
-
Alcaraz to return for US Open title defence
Mesothelioma Hope Interviews UNC Lineberger Oncologist Dr. Carrie Lee on Clinical Trials, Immunotherapy, and Maintaining Hope During Treatment
The medical oncologist and Chief Medical Officer for Clinical Research at UNC Lineberger Comprehensive Cancer Center shares insights on tumor testing, multidisciplinary care, and why clinical trials shouldn't be viewed as a last resort.
CHESTNUT HILL, MA / ACCESS Newswire / August 4, 2026 / Mesothelioma Hope, a leading online resource providing education, patient advocacy, and support for those diagnosed with mesothelioma, has published a new interview with Dr. Carrie B. Lee, a medical oncologist and professor at the UNC School of Medicine who has spent more than two decades treating mesothelioma and lung cancer patients.
The full interview is available at MesotheliomaHope.com.
In the Q&A, Dr. Lee discusses how far mesothelioma treatment has come since she entered the field, when advanced-stage patients were considered essentially incurable. She points to the emergence of immunotherapy as a turning point, noting that some patients with advanced disease are now achieving remission and long-term survival - outcomes that were unthinkable a generation ago.
Key Takeaways From the Interview
Clinical Trials Aren't a Last Resort - Dr. Lee emphasized that clinical trials can be appropriate at the time of initial diagnosis, not just after other treatments are exhausted. She encouraged patients to ask their providers about trials early on and to contact patient advocacy organizations that can help match them with active studies.
Comprehensive Tumor Testing Matters - DNA and RNA sequencing can uncover genetic mutations that affect prognosis and open the door to targeted therapies or clinical trials that patients might not otherwise learn about.
Multidisciplinary Care Improves Outcomes - Dr. Lee described how medical oncologists, radiation oncologists, and surgeons collaborate on tumor boards to ensure that each patient's treatment plan reflects input from all relevant specialists.
Second Opinions From Specialty Centers - Because mesothelioma is rare, Dr. Lee recommends that patients seek at least one opinion from an academic cancer center experienced in treating the disease, even if ongoing care ultimately happens closer to home.
Redefining Hope During Treatment - Dr. Lee spoke candidly about how hope shifts depending on a patient's circumstances, from pursuing a cure in early-stage disease to prioritizing quality of life and comfort in more advanced cases.
"Even when the most serious circumstances arise, I never want to remove all hope," said Dr. Lee. "Sometimes things happen that we can't explain. The longer I do this, the more I realize that we're not in charge, and that we're here to love, help, and provide care and support for each other."
How Mesothelioma Hope Supports Patients
Mesothelioma Hope's Patient Advocates are available 24/7 to help patients and families:
Connect with mesothelioma specialists and academic cancer centers
Identify clinical trials that match a patient's diagnosis and treatment history
Access free educational guides covering treatment, prognosis, and legal options
Find support groups and financial assistance resources
A free 2026 Mesothelioma Guide is available at www.mesotheliomahope.com/mesothelioma-guide.
About Mesothelioma Hope
Mesothelioma Hope is a comprehensive patient support resource dedicated to helping individuals diagnosed with mesothelioma and their families access the information, specialists, and support they need. Through its team of Patient Advocates, the organization provides free guidance on treatment options, clinical trials, financial assistance, and legal resources. Mesothelioma Hope can be reached 24/7 by calling (866) 608-8933 or by visiting www.mesotheliomahope.com.
MEDIA CONTACT
Chris Carberg
(855) 346-6101
[email protected]
1330 Boylston St, Suite #400, Chestnut Hill, MA 02467
SOURCE: Mesothelioma Hope
View the original press release on ACCESS Newswire
Ch.Campbell--AT